Metabolic Brain Disease

, Volume 25, Issue 1, pp 91–96

100 cc 3% sodium chloride bolus: a novel treatment for hyponatremic encephalopathy

Original Paper

Abstract

Hyponatremic encephalopathy is a potentially lethal condition with numerous reports of death or permanent neurological injury. The optimal treatment for hyponatremic encephalopathy remains controversial. We have introduced a unified approach to the treatment of hyponatremic encephalopathy which uses 3% NaCl (513 mEq/L) bolus therapy. Any patient with suspected hyponatremic encephalopathy should receive a 2 cc/kg bolus of 3% NaCl with a maximum of 100 cc, which could be repeated 1–2 times if symptoms persist. The approach results in a controlled and immediate rise in serum sodium with little risk of inadvertent overcorrection.

Keywords

Hyponatremia Encephalopathy Fluid therapy Myelinolysis Arginine vasopressin 

References

  1. Arieff AI, Ayus JC et al (1992) Hyponatraemia and death or permanent brain damage in healthy children. BMJ 304(6836):1218–1222CrossRefPubMedGoogle Scholar
  2. Arieff AI, Kozniewska E et al (1995) Age, gender, and vasopressin affect survival and brain adaptation in rats with metabolic encephalopathy. Am J Physiol 268(5 Pt 2):R1143–R1152PubMedGoogle Scholar
  3. Ayus JC, Achinger SG et al (2008) Brain cell volume regulation in hyponatremia: role of sex, age, vasopressin, and hypoxia. Am J Physiol Renal Physiol 295(3):F619–F624CrossRefPubMedGoogle Scholar
  4. Ayus JC, Arieff A et al (2005) Hyponatremia in marathon runners. N Engl J Med 353(4):427–428CrossRefPubMedGoogle Scholar
  5. Ayus JC, Arieff AI (1993) Pathogenesis and prevention of hyponatremic encephalopathy. Endocrinol Metab Clin North Am 22(2):425–446PubMedGoogle Scholar
  6. Ayus JC, Arieff AI (1995) Pulmonary complications of hyponatremic encephalopathy. Noncardiogenic pulmonary edema and hypercapnic respiratory failure. Chest 107(2):517–521CrossRefPubMedGoogle Scholar
  7. Ayus JC, Arieff AI (1996) Brain damage and postoperative hyponatremia: the role of gender. Neurology 46(2):323–328PubMedGoogle Scholar
  8. Ayus JC, Arieff AI (1999) Chronic hyponatremic encephalopathy in postmenopausal women: association of therapies with morbidity and mortality. JAMA 281(24):2299–2304CrossRefPubMedGoogle Scholar
  9. Ayus JC, Arieff AI (2002a) Therapy of dDAVP-associated hyponatremia can lead to permanent brain damage. J Am Soc Nephrol 13:671AGoogle Scholar
  10. Ayus, J. C. and A. I. Arieff (2002b) Therapy of dDAVP-associated hyponatremia can lead to permanent brain damage. J Am Soc Nephrol 13: PUB002.Google Scholar
  11. Ayus JC, Armstrong D et al (2006) Hyponatremia with hypoxia: effects on brain adaptation, perfusion, and histology in rodents. Kidney Int 69(8):1319–1325PubMedGoogle Scholar
  12. Ayus JC, Krothapalli RK et al (1987) Treatment of symptomatic hyponatremia and its relation to brain damage. A prospective study. N Engl J Med 317(19):1190–1195PubMedGoogle Scholar
  13. Ayus JC, Krothapalli RK et al (1985) Rapid correction of severe hyponatremia in the rat: histopathological changes in the brain. Am J Physiol 248(5 Pt 2):F711–F719PubMedGoogle Scholar
  14. Ayus JC, Krothapalli RK et al (1989) Symptomatic hyponatremia in rats: effect of treatment on mortality and brain lesions. Am J Physiol 257(1 Pt 2):F18–F22PubMedGoogle Scholar
  15. Ayus JC, Varon J et al (2000) Hyponatremia, cerebral edema, and noncardiogenic pulmonary edema in marathon runners. Ann Intern Med 132(9):711–714PubMedGoogle Scholar
  16. Ayus JC, Wheeler JM et al (1992) Postoperative hyponatremic encephalopathy in menstruant women. Ann Intern Med 117(11):891–897PubMedGoogle Scholar
  17. Campbell GA, Rosner MH (2008) The agony of ecstasy: MDMA (3,4-methylenedioxymethamphetamine) and the kidney. Clin J Am Soc Nephrol 3(6):1852–1860CrossRefPubMedGoogle Scholar
  18. Decaux G, Soupart A (2003) Treatment of symptomatic hyponatremia. Am J Med Sci 326(1):25–30CrossRefPubMedGoogle Scholar
  19. Decaux G, Soupart A et al (2008) Non-peptide arginine-vasopressin antagonists: the vaptans. Lancet 371(9624):1624–1632CrossRefPubMedGoogle Scholar
  20. Dellabarca C, Servilla KS et al (2005) Osmotic myelinolysis following chronic hyponatremia corrected at an overall rate consistent with current recommendations. Int Urol Nephrol 37(1):171–173CrossRefPubMedGoogle Scholar
  21. Doczi T, Laszlo FA et al (1984) Involvement of vasopressin in brain edema formation: further evidence obtained from the Brattleboro diabetes insipidus rat with experimental subarachnoid hemorrhage. Neurosurgery 14(4):436–441PubMedCrossRefGoogle Scholar
  22. Gankam Kengne F, Soupart A et al (2009) Re-induction of hyponatremia after rapid overcorrection of hyponatremia reduces mortality in rats. Kidney Int 76(6):614–621CrossRefPubMedGoogle Scholar
  23. Georgy V, Mullhi D et al (2007) Central pontine myelinolysis following ‘optimal’ rate of correction of hyponatraemia with a good clinical outcome. Ann Clin Biochem 44(Pt 5):488–490CrossRefPubMedGoogle Scholar
  24. Germiniani FM, Roriz M et al (2002) [Central pontine and extra-pontine myelinolysis in an alcoholic patient without hydro-electrolyte disturbances: case report]. Arq Neuropsiquiatr 60(4):1030–1033PubMedGoogle Scholar
  25. Goldszmidt MA, Iliescu EA (2000) DDAVP to prevent rapid correction in hyponatremia. Clin Nephrol 53(3):226–229PubMedGoogle Scholar
  26. Hagiwara K, Okada Y et al (2008) Extensive central and extrapontine myelinolysis in a case of chronic alcoholism without hyponatremia: a case report with analysis of serial MR findings. Intern Med 47(5):431–435CrossRefPubMedGoogle Scholar
  27. Hew-Butler T, Ayus JC et al (2008) Statement of the Second International Exercise-Associated Hyponatremia Consensus Development Conference, New Zealand, 2007. Clin J Sport Med 18(2):111–121CrossRefPubMedGoogle Scholar
  28. Hoorn EJ, Lindemans J et al (2006) Development of severe hyponatraemia in hospitalized patients: treatment-related risk factors and inadequate management. Nephrol Dial Transplant 21(1):70–76CrossRefPubMedGoogle Scholar
  29. Huda MS, Boyd A et al (2006) Investigation and management of severe hyponatraemia in a hospital setting. Postgrad Med J 82(965):216–219CrossRefPubMedGoogle Scholar
  30. Kalantar-Zadeh K, Nguyen MK et al (2006) Fatal hyponatremia in a young woman after ecstasy ingestion. Nat Clin Pract Nephrol 2(5):283–288, quiz 289CrossRefPubMedGoogle Scholar
  31. Kimelberg HK (2004) Increased release of excitatory amino acids by the actions of ATP and peroxynitrite on volume-regulated anion channels (VRACs) in astrocytes. Neurochem Int 45(4):511–519CrossRefPubMedGoogle Scholar
  32. Kozniewska E, Gadamski R et al (2008) Morphological changes in the brain during experimental hyponatraemia. Do vasopressin and gender matter? Folia Neuropathol 46(4):271–277PubMedGoogle Scholar
  33. Lauriat SM, Berl T (1997) The hyponatremic patient: practical focus on therapy. J Am Soc Nephrol 8(10):1599–1607PubMedGoogle Scholar
  34. McClellan MD, Dauber IM et al (1989) Elevated intracranial pressure increases pulmonary vascular permeability to protein. J Appl Physiol 67(3):1185–1191PubMedGoogle Scholar
  35. Montanana PA, iAlapont Modesto et al (2008) The use of isotonic fluid as maintenance therapy prevents iatrogenic hyponatremia in pediatrics: a randomized, controlled open study. Pediatr Crit Care Med 9(6):589–597CrossRefPubMedGoogle Scholar
  36. Moritz ML, Ayus JC (2001) La Crosse encephalitis in children. N Engl J Med 345(2):148–149CrossRefPubMedGoogle Scholar
  37. Moritz ML, Ayus JC (2003) Prevention of hospital-acquired hyponatremia: a case for using isotonic saline. Pediatrics 111(2):227–230CrossRefPubMedGoogle Scholar
  38. Moritz ML, Ayus JC (2005) Preventing neurological complications from dysnatremias in children. Pediatr Nephrol 20(12):1687–1700CrossRefPubMedGoogle Scholar
  39. Moritz ML, Ayus JC (2008) Exercise-associated hyponatremia: why are athletes still dying? Clin J Sport Med 18(5):379–381CrossRefPubMedGoogle Scholar
  40. Moritz, M. L. and J. C. Ayus (2009) New aspects in the pathogenesis, prevention, and treatment of hyponatremic encephalopathy in children. Pediatr Nephrol [Epub ahead of print].Google Scholar
  41. Moritz ML, Carlos Ayus J (2007) Hospital-acquired hyponatremia-why are hypotonic parenteral fluids still being used? Nat Clin Pract Nephrol 3(7):374–382CrossRefPubMedGoogle Scholar
  42. Nagaishi A, Yukitake M et al (2007) [A case of alcoholic with vitamin B12 deficiency presenting central pontine and extrapontine myelinolysis on MRI]. Rinsho Shinkeigaku 47(4):173–176PubMedGoogle Scholar
  43. Neville, K. A., D. J. Sandeman, et al. (2009) Prevention of Hyponatremia during Maintenance Intravenous Fluid Administration: A Prospective Randomized Study of Fluid Type versus Fluid Rate. J Pediatr 156(2):313–319. [Epub 2009 Oct 9].Google Scholar
  44. Nzerue C, Baffoe-Bonnie H et al (2002) Predicters of mortality with severe hyponatremia. J Am Soc Nephrol 13:A0728Google Scholar
  45. Orakzai RH, Orakzai SH et al (2008) Treating hyponatremia: how slow is safe? Central pontine myelinolysis despite appropriate correction of hyponatremia. Eur J Intern Med 19(6):e29–e31CrossRefPubMedGoogle Scholar
  46. Palmer BF, Sterns RH (2009) Fluid, Electrolytes and Acid-Base Disturbances. Nephrol Self Assess Program 8(2):136–142Google Scholar
  47. Perianayagam A, Sterns RH et al (2008) DDAVP is effective in preventing and reversing inadvertent overcorrection of hyponatremia. Clin J Am Soc Nephrol 3(2):331–336CrossRefPubMedGoogle Scholar
  48. Pradhan S, Jha R et al (1995) Central pontine myelinolysis following ‘slow’ correction of hyponatremia. Clin Neurol Neurosurg 97(4):340–343CrossRefPubMedGoogle Scholar
  49. Savasta S, Sepe V et al (2006) Severe hyponatremia followed by extrapontine myelinolysis. Kidney Int 69(3):423CrossRefPubMedGoogle Scholar
  50. Schoonman GG, Sandor PS et al (2008) Hypoxia-induced acute mountain sickness is associated with intracellular cerebral edema: a 3 T magnetic resonance imaging study. J Cereb Blood Flow Metab 28(1):198–206CrossRefPubMedGoogle Scholar
  51. Schuster M, Diekmann S et al (2009) Central pontine myelinolysis despite slow sodium rise in a case of severe community-acquired hyponatraemia. Anaesth Intensive Care 37(1):117–120PubMedGoogle Scholar
  52. Smith WS, Matthay MA (1997) Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest 111(5):1326–1333CrossRefPubMedGoogle Scholar
  53. Soupart A, Penninckx R et al (1992) Treatment of chronic hyponatremia in rats by intravenous saline: comparison of rate versus magnitude of correction. Kidney Int 41(6):1662–1667CrossRefPubMedGoogle Scholar
  54. Sterns RH, Nigwekar SU et al (2009) The treatment of hyponatremia. Semin Nephrol 29(3):282–299CrossRefPubMedGoogle Scholar
  55. Sundgren PC, Reinstrup P et al (2002) Value of conventional, and diffusion-and perfusion weighted MRI in the management of patients with unclear cerebral pathology, admitted to the intensive care unit. Neuroradiology 44(8):674–680CrossRefPubMedGoogle Scholar
  56. Tan H, Onbas O (2004) Central pontine myelinolysis central pontine myelinolysis manifesting with massive myoclonus. Pediatr Neurol 31(1):64–66CrossRefPubMedGoogle Scholar
  57. Vajda Z, Pedersen M et al (2001) Effects of centrally administered arginine vasopressin and atrial natriuretic peptide on the development of brain edema in hyponatremic rats. Neurosurgery 49(3):697–704, discussion 704–5CrossRefPubMedGoogle Scholar
  58. Verbalis JG, Martinez AJ (1991) Neurological and neuropathological sequelae of correction of chronic hyponatremia. Kidney Int 39(6):1274–1282CrossRefPubMedGoogle Scholar
  59. Vexler ZS, Ayus JC et al (1994) Hypoxic and ischemic hypoxia exacerbate brain injury associated with metabolic encephalopathy in laboratory animals. J Clin Invest 93(1):256–264CrossRefPubMedGoogle Scholar
  60. Yoon B, Shim YS et al (2008) Central pontine and extrapontine myelinolysis after alcohol withdrawal. Alcohol Alcohol 43(6):647–649PubMedGoogle Scholar
  61. Yung M, Keeley S (2009) Randomised controlled trial of intravenous maintenance fluids. J Paediatr Child Health 45(1–2):9–14CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  1. 1.Division of Nephrology, Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMCThe University of Pittsburgh School of MedicinePittsburghUSA
  2. 2.Renal Consultants of HoustonHoustonUSA

Personalised recommendations